Penumbra Market Capitalization from 2010 to 2024
| PEN Stock | USD 244.15 0.00 0.00% |
Check Penumbra financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Penumbra's main balance sheet or income statement drivers, such as Interest Expense of 1.7 M, Total Revenue of 1.1 B or Gross Profit of 716.8 M, as well as many indicators such as Price To Sales Ratio of 7.88, Dividend Yield of 0.0 or PTB Ratio of 8.6. Penumbra financial statements analysis is a perfect complement when working with Penumbra Valuation or Volatility modules.
Penumbra | Market Capitalization |
Latest Penumbra's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Penumbra over the last few years. It is Penumbra's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Penumbra's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 9.55 B | 10 Years Trend |
|
Market Cap |
| Timeline |
Penumbra Market Capitalization Regression Statistics
| Arithmetic Mean | 4,681,226,357 | |
| Geometric Mean | 2,920,391,506 | |
| Coefficient Of Variation | 87.05 | |
| Mean Deviation | 3,595,667,715 | |
| Median | 3,103,235,916 | |
| Standard Deviation | 4,074,947,595 | |
| Sample Variance | 16605197.9T | |
| Range | 9.9B | |
| R-Value | 0.91 | |
| Mean Square Error | 3061043.8T | |
| R-Squared | 0.83 | |
| Slope | 829,542,045 | |
| Total Sum of Squares | 232472770.6T |
Penumbra Market Capitalization History
About Penumbra Financial Statements
Penumbra investors utilize fundamental indicators, such as Market Capitalization, to predict how Penumbra Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California. Penumbra operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 3800 people.
Check out the analysis of Penumbra Correlation against competitors. To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Penumbra. If investors know Penumbra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Penumbra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.261 | Earnings Share 0.87 | Revenue Per Share 30.081 | Quarterly Revenue Growth 0.111 | Return On Assets 0.0333 |
The market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. Investors also form their own opinion of Penumbra's value that differs from its market value or its book value, called intrinsic value, which is Penumbra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Penumbra's market value can be influenced by many factors that don't directly affect Penumbra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Penumbra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Penumbra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Penumbra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.